Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04536090
Recruitment Status : Not yet recruiting
First Posted : September 2, 2020
Last Update Posted : August 23, 2021
Pharmascience Inc.
SCiAN Services, Inc.
Quercis Pharma AG
Information provided by (Responsible Party):
Institut de Recherches Cliniques de Montreal